PharmaShots | Incisive News in 3 Shots

Subscribe Now

Acutely Ill Patients

Bayer and Janssen's Xarelto (rivaroxaban) Receive FDA's Approval to Prevent Venous Thromboembolism in Acutely Ill Patients

Bayer and Janssen's Xarelto (rivaroxaban) Receive FDA's Approval to Prevent Venous Thromboembolism in Acutely Ill Patients

October 15, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us